Literature DB >> 10782799

Intracranial calcifications in childhood medulloblastoma: relation to nevoid basal cell carcinoma syndrome.

T Stavrou1, E C Dubovsky, G H Reaman, A M Goldstein, G Vezina.   

Abstract

BACKGROUND AND
PURPOSE: Medulloblastoma is one of the most common posterior fossa tumors to occur in children. Our purpose was to document the frequency, location, and time of occurrence of intracranial calcifications in cranial CT studies of children with medulloblastoma.
METHODS: We retrospectively reviewed cranial CT studies of 56 patients diagnosed with medulloblastoma from 1983 through 1997 for the presence of intracranial calcifications. The findings were compared with 159 cranial CT studies of patients who were evaluated in the emergency department (control group). Thirty-two patients with medulloblastoma without shunts were compared with 118 patients from the control group without shunts. Similarly, 24 patients with medulloblastoma with shunts were compared with 41 patients from the control group with shunts.
RESULTS: Overall, three (9%) patients with medulloblastoma without shunts, four (16%) patients with medulloblastoma with shunts, and four (10%) patients from the control group with shunts had falx calcification. Only the two children carrying the diagnoses of medulloblastoma and nevoid basal cell carcinoma syndrome, however, had calcification of the falx cerebri shown on the cranial CT scans obtained during the peridiagnostic period. Both were diagnosed with medulloblastoma before the age of 3 years and later developed jaw cysts and multiple basal cell carcinomas in the radiation field.
CONCLUSION: Previous studies have shown that falx calcification is a major component of nevoid basal cell carcinoma syndrome. Our two cases illustrate the importance of considering the diagnosis of nevoid basal cell carcinoma syndrome when falx calcification is present in young patients with medulloblastoma. If the concomitant diagnosis of nevoid basal cell carcinoma syndrome is made, alternative types of therapy should be sought to minimize radiation therapy sequelae.

Entities:  

Mesh:

Year:  2000        PMID: 10782799      PMCID: PMC7976642     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  15 in total

1.  Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I).

Authors:  D M Tait; H Thornton-Jones; H J Bloom; J Lemerle; P Morris-Jones
Journal:  Eur J Cancer       Date:  1990-04       Impact factor: 9.162

2.  Intracranial calcifications in childhood. Frequency of occurrence and significance.

Authors:  W L Schey
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1974-11

3.  Intracranial physiologic calcifications.

Authors:  S A Kieffer; L H Gold
Journal:  Semin Roentgenol       Date:  1974-04       Impact factor: 0.800

4.  Relative detectability of intracranial calcifications on computed tomography and skull radiography.

Authors:  D Norman; C Diamond; D Boyd
Journal:  J Comput Assist Tomogr       Date:  1978-01       Impact factor: 1.826

5.  Nevoid basal cell carcinoma syndrome: radiographic manifestations including cystlike lesions of the phalanges.

Authors:  N R Dunnick; G L Head; G L Peck; F W Yoder
Journal:  Radiology       Date:  1978-05       Impact factor: 11.105

6.  Medulloblastoma: is the 5-year survival rate improving? A review of 80 cases from a single institution.

Authors:  K M David; A T Casey; R D Hayward; W F Harkness; K Phipps; A M Wade
Journal:  J Neurosurg       Date:  1997-01       Impact factor: 5.115

7.  Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991.

Authors:  F G Davis; S Freels; J Grutsch; S Barlas; S Brem
Journal:  J Neurosurg       Date:  1998-01       Impact factor: 5.115

Review 8.  Nevoid basal-cell carcinoma syndrome.

Authors:  R J Gorlin
Journal:  Medicine (Baltimore)       Date:  1987-03       Impact factor: 1.889

9.  Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.

Authors:  R J Packer; L N Sutton; R Elterman; B Lange; J Goldwein; H S Nicholson; L Mulne; J Boyett; G D'Angio; K Wechsler-Jentzsch
Journal:  J Neurosurg       Date:  1994-11       Impact factor: 5.115

Review 10.  The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma.

Authors:  D G Evans; P A Farndon; L D Burnell; H R Gattamaneni; J M Birch
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

View more
  4 in total

1.  [Calcification of the falx cerebri. A pathognomonic symptom of Gorlin-Goltz syndrome].

Authors:  J T Lambrecht; S Stübinger; B Siewert; F Härle
Journal:  HNO       Date:  2005-08       Impact factor: 1.284

2.  Gorlin-Goltz syndrome: a rare case report.

Authors:  Ravi Prakash Sasankoti Mohan; Sankalp Verma; Neha Agarwal; Udita Singh
Journal:  BMJ Case Rep       Date:  2013-06-27

Review 3.  Nevoid basal cell carcinoma syndrome (Gorlin syndrome).

Authors:  Lorenzo Lo Muzio
Journal:  Orphanet J Rare Dis       Date:  2008-11-25       Impact factor: 4.123

4.  Neuroimaging of nevoid basal cell carcinoma syndrome (NBCCS) in children.

Authors:  Kamyar Sartip; Adam Kaplan; George Obeid; Nadja Kadom
Journal:  Pediatr Radiol       Date:  2012-11-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.